- Home
- TEVA vs AFRM Comparison
TEVA vs AFRM Comparison
Compare TEVA & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- AFRM
- Stock Information
- Founded
- TEVA 1901
- AFRM 2012
- Country
- TEVA Israel
- AFRM United States
- Employees
- TEVA N/A
- AFRM N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- AFRM Business Services
- Sector
- TEVA Health Care
- AFRM Consumer Discretionary
- Exchange
- TEVA Nasdaq
- AFRM Nasdaq
- Market Cap
- TEVA 20.1B
- AFRM 19.1B
- IPO Year
- TEVA N/A
- AFRM 2021
- Fundamental
- Price
- TEVA $16.65
- AFRM $67.34
- Analyst Decision
- TEVA Strong Buy
- AFRM Buy
- Analyst Count
- TEVA 8
- AFRM 22
- Target Price
- TEVA $24.50
- AFRM $65.89
- AVG Volume (30 Days)
- TEVA 10.6M
- AFRM 6.0M
- Earning Date
- TEVA 07-30-2025
- AFRM 08-27-2025
- Dividend Yield
- TEVA N/A
- AFRM N/A
- EPS Growth
- TEVA N/A
- AFRM N/A
- EPS
- TEVA N/A
- AFRM N/A
- Revenue
- TEVA $16,616,000,000.00
- AFRM $3,007,180,000.00
- Revenue This Year
- TEVA $5.69
- AFRM $39.73
- Revenue Next Year
- TEVA N/A
- AFRM $22.49
- P/E Ratio
- TEVA N/A
- AFRM N/A
- Revenue Growth
- TEVA 3.82
- AFRM 42.55
- 52 Week Low
- TEVA $12.47
- AFRM $22.25
- 52 Week High
- TEVA $22.80
- AFRM $82.53
- Technical
- Relative Strength Index (RSI)
- TEVA 45.87
- AFRM 71.62
- Support Level
- TEVA $16.42
- AFRM $59.68
- Resistance Level
- TEVA $16.95
- AFRM $69.75
- Average True Range (ATR)
- TEVA 0.46
- AFRM 2.21
- MACD
- TEVA -0.11
- AFRM 0.52
- Stochastic Oscillator
- TEVA 16.79
- AFRM 89.88
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About AFRM Affirm Holdings Inc.
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.